Delivery Order SPE2DB25D9306-SPE2DB25FXGWH
Award Date
4/22/25
Potential Completion Date
5/13/25
Potential Value
$1.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $1,772.79 contract is for the delivery of 4,564,374,023 units of the YF-VAX 1 dose vaccine and has an ultimate completion date of April 24, 2024. DMS Pharmaceutical Group Inc. is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of pharmaceutical products and medical...
This is a $1,690.47 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for 4,565,058,724 doses of the YF-VAX vaccine, with a completion date of June 24, 2024. This delivery order is part of a larger indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA, running through December...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The $27,835.50 contract is for the supply of 4,567,268,544 doses of the YF-VAX 1 DOSE VIALS product, with a performance period ending on March 6, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, enabling the agency to issue delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract has a ceiling value of $54,730.00 and covers the delivery of 4,562,879 units of the YF-VAX 1 dose vaccine vials. The order was placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract with the DLA, which provides a wide range of pharmaceutical products and medical supplies to support...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract, valued at $10,577.49, is for the delivery of 4,566,975,630 vials of the YF-VAX 1 dose vaccine. This award is part of a larger Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the DLA, valued at $499,999,999 and valid through November 2026. The IDC allows the DLA to issue firm...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, for the procurement of 4,563,153,330 units of the YF-VAX 1 dose vaccine. The contract, valued at $1,094.62, has an ultimate completion date of January 8, 2024. DMS Pharmaceutical Group is a key supplier in the federal pharmaceutical supply chain, providing a comprehensive range of branded and generic prescription...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler. The contract is for the delivery of 4,568,037,215 vials of the YF-VAX 1 dose vaccine, with a ceiling value of $2,783.55 and a completion date of May 14, 2025. The contract is not associated with a set-aside program. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC)...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract is for the delivery of 4,568,027,479 vials of the YF-VAX 1 dose vaccine, with a ceiling value of $1,670.13 and a period of performance through May 8, 2025. DMS Pharmaceutical Group holds a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999 and valid through November...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business. The contract, valued at $16,701.30, is for the delivery of 4,567,979,698 units of the YF-VAX 1 dose vaccine. The contract has a period of performance through May 6, 2025. DMS Pharmaceutical Group Inc. has a larger Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, valued at $499,999,999, which allows the agency...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $1,670.13, is for the delivery of 4,567,939,520 units of the YF-VAX 1 dose vaccine. The contract has an ultimate completion date of May 1, 2025 and does not have a set-aside designation. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite...